Statins, the commonly prescribed class of drugs to reduce cardiovascular disease risk, are identified as a potential microbiota-modulating therapeutic, according to a new study. The microbiome, the genetic material of all microorganisms that live in the human body, is essential for development, immunity and nutrition. Cardiometabolic diseases (CMDs) like heart disease and metabolic disorders such […]
Antimicrobial resistance in the EU: infections with foodborne bacteria becoming harder to treat
The latest data from humans, animals, and food show that a large proportion of Salmonella bacteria are multidrug-resistant. In humans, resistance to ciprofloxacin is common, particularly in certain types of Salmonella, and resistance to high concentrations of ciprofloxacin increased overall from 1.7% (2016) to 4.6% (2018). For Campylobacter, 16 out of 19 countries report very high or extremely high […]